Join Now

Author Archives: Press Release

ENPICOM and Carterra Advance Antibody Screening by Integrating Biophysical Characterization and Repertoire Sequencing Analysis

By allowing Carterra’s superior epitope, binding affinity, and kinetic information to occupy the same view as sequence information, the IGX Platform enables faster, better decision-making in therapeutic discovery.

Posted in BioUtah News | Tagged , | Comments Off on ENPICOM and Carterra Advance Antibody Screening by Integrating Biophysical Characterization and Repertoire Sequencing Analysis

National Registry Names Intermountain Health’s Transplant Program as Nation’s Top Program for Successfully Matching Donated Kidneys to Patients

National Registry Names Intermountain Health’s Transplant Program as Nation’s Top Program for Successfully Matching Donated Kidneys to Patients

Posted in BioUtah News | Tagged | Comments Off on National Registry Names Intermountain Health’s Transplant Program as Nation’s Top Program for Successfully Matching Donated Kidneys to Patients

Merit Medical Announces Process for Chief Executive Officer Succession Planning

Merit Medical Announces Process for Chief Executive Officer Succession Planning

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Announces Process for Chief Executive Officer Succession Planning

Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

Posted in BioUtah News | Tagged | Comments Off on Spectrum Solutions Names Bill Phillips as New Chief Executive Officer

MasterControl Solutions Inc., Expands in Salt Lake County

$40 million capex, 155 jobs, Project Orange

Posted in BioUtah News | Tagged | Comments Off on MasterControl Solutions Inc., Expands in Salt Lake County

BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations

Posted in BioUtah News | Tagged | Comments Off on BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

Halia Therapeutics co-founder David J. Bearss Featured in Utah Business

Utah Business recently featured Halia Therapeutics co-founder David Bearss in their Founder Series

Posted in BioUtah News | Tagged | Comments Off on Halia Therapeutics co-founder David J. Bearss Featured in Utah Business

BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems

BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems

Posted in BioUtah News | Tagged | Comments Off on BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems

Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA

Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA

Posted in BioUtah News | Tagged | Comments Off on Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA

BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency

SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success

Posted in BioUtah News | Tagged | Comments Off on BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency

Seek Labs Announces Completion of Office Expansion to Support Business Growth

Seek Labs Announces Completion of Office Expansion to Support Business Growth

Posted in BioUtah News | Tagged | Comments Off on Seek Labs Announces Completion of Office Expansion to Support Business Growth

Biolexis Therapeutics launches subsidiary Metabolexis to develop novel oral medicines for Obesity and Type 2 Diabetes to improve human longevity

Metabolexis focuses on GLP-1 weight loss and type 2 diabetic drug discoveries to improve accessibility and meet unprecedented demand.

Posted in BioUtah News | Tagged | Comments Off on Biolexis Therapeutics launches subsidiary Metabolexis to develop novel oral medicines for Obesity and Type 2 Diabetes to improve human longevity